Abstract | BACKGROUND:
Alosetron reduces symptoms of dyspepsia, but the physiological basis for the symptomatic benefit is unclear. AIM: To assess 5-HT3 antagonism on postprandial gastric volume and symptoms after ingestion of maximum tolerable volume of a liquid meal. METHODS: In 36 healthy volunteers, we assessed effects of placebo, 0.5 and 1 mg b.d. alosetron on fasting and postprandial gastric volumes (using single photon emission computed tomography) and symptoms based on 100 mm VAS, 30 min after maximum volume ingested. RESULTS: The 5-HT3 antagonist reduced postprandial symptoms (aggregate score: P < 0.05), nausea (P < 0.001), and tended to reduce bloating (P=0.08). Both 0.5 and 1 mg alosetron reduced nausea (P < 0.025); 1 mg alosetron reduced aggregate symptoms (P < 0.05) and bloating (P < 0.05). Effects on pain (P=0.19) and fullness (P=0.14) were not statistically significant. There were no significant effects of the 5-HT3 antagonist on volume of meal tolerated or on SPECT-measured fasting or postprandial gastric volumes. CONCLUSION: 5-HT3 antagonism reduces aggregate symptoms, nausea and bloating after a liquid meal without increase in gastric volumes, suggesting a role for 5-HT3 in afferent functions in healthy humans during the postprandial period.
|
Authors | B Kuo, M Camilleri, D Burton, B Viramontes, S McKinzie, G Thomforde, M K O'Connor, B H Brinkmann |
Journal | Alimentary pharmacology & therapeutics
(Aliment Pharmacol Ther)
Vol. 16
Issue 2
Pg. 225-33
(Feb 2002)
ISSN: 0269-2813 [Print] England |
PMID | 11860405
(Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
|
Chemical References |
- Carbolines
- Dietary Sucrose
- Serotonin Antagonists
- Ensure formulated food
- alosetron
|
Topics |
- Adult
- Carbolines
(administration & dosage, adverse effects, therapeutic use)
- Dietary Sucrose
(administration & dosage, adverse effects)
- Dose-Response Relationship, Drug
- Double-Blind Method
- Fasting
- Female
- Food, Formulated
- Humans
- Linear Models
- Male
- Nausea
(prevention & control)
- Pain Measurement
- Postprandial Period
(drug effects)
- Serotonin Antagonists
(administration & dosage, adverse effects, therapeutic use)
- Stomach
(drug effects)
- Tomography, Emission-Computed, Single-Photon
|